Wealth Enhancement Advisory Services LLC Purchases 18,699 Shares of Envista Holdings Corporation $NVST

Wealth Enhancement Advisory Services LLC grew its holdings in shares of Envista Holdings Corporation (NYSE:NVST) by 39.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 66,018 shares of the company’s stock after buying an additional 18,699 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Envista were worth $1,346,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. GAMMA Investing LLC lifted its stake in shares of Envista by 1,338.3% in the first quarter. GAMMA Investing LLC now owns 33,139 shares of the company’s stock valued at $572,000 after buying an additional 30,835 shares in the last quarter. First Hawaiian Bank lifted its stake in shares of Envista by 47.4% in the first quarter. First Hawaiian Bank now owns 47,597 shares of the company’s stock valued at $822,000 after buying an additional 15,312 shares in the last quarter. Strs Ohio bought a new position in Envista in the 1st quarter valued at about $1,433,000. Pallas Capital Advisors LLC bought a new position in Envista in the 2nd quarter valued at about $300,000. Finally, Bayforest Capital Ltd lifted its position in Envista by 956.8% in the 1st quarter. Bayforest Capital Ltd now owns 42,982 shares of the company’s stock valued at $742,000 after acquiring an additional 38,915 shares in the last quarter.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. UBS Group raised their target price on Envista from $18.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, July 29th. Morgan Stanley raised their price objective on Envista from $16.00 to $17.00 and gave the company an “equal weight” rating in a research note on Friday, August 1st. Wells Fargo & Company raised their price objective on Envista from $17.00 to $19.00 and gave the company an “equal weight” rating in a research note on Friday, August 1st. Piper Sandler raised their price target on shares of Envista from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Friday, August 1st. Finally, Zacks Research lowered shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.92.

Envista Trading Up 0.7%

Shares of NVST stock opened at $20.37 on Wednesday. The company’s fifty day simple moving average is $20.72 and its two-hundred day simple moving average is $18.79. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.44 and a quick ratio of 2.08. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $23.00. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 63.66, a PEG ratio of 1.08 and a beta of 0.99.

Envista (NYSE:NVST) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same period in the previous year, the company posted $0.11 EPS. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. As a group, analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.